母体甲减与新生儿甲减的关系及TSH达标治疗对患儿甲减发病率的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省卫生厅科研课题(120113)


Study on the relationship between maternal hypothyroidism and neonatal hypothyroidism and the effect of TSH goaldirected therapy on the incidence of hypothyroidism in children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨孕妇甲减与新生儿甲减的关系及血清促甲状腺激素(TSH)达标治疗对患儿甲减发病率的影响。方法 回顾性分析2012年1月~2015年1月来院就诊的58例妊娠合并甲状腺功能减退症(甲减)孕妇和67例妊娠合并亚临床甲状腺功能减退孕妇分别作为临床甲减组和亚临床甲减组,选取同期医院孕检的60例甲状腺功能正常孕妇作为对照组。125例妊娠合并甲减或亚甲减孕妇中,95例接受左旋甲状腺激素(LT4)治疗(LT4治疗组),其中71例血清促甲状腺激素达标(达标组),24例TSH未达标(未达标组),30例未接受LT4治疗(非LT4治疗组)。比较LT4治疗组、非LT4治疗组及对照组产妇终止妊娠时及新生儿甲状腺功能指标,并记录各组新生儿甲减发生率。结果 非LT4治疗组孕妇、新生儿TSH高于LT4治疗组和对照组(P<005),LT4治疗组和对照组孕妇组间对比差异无统计学意义(P>005);三组孕妇血清游离甲状腺素(FT4)比较差异无统计学意义(P>005);非LT4治疗组新生儿甲减发生率2333%高于LT4治疗组842%和对照组000%,LT4治疗组和对照组组间比较差异无统计学意义(P>005);临床甲减组和亚临床甲减组新生儿甲减发生率比较差异无统计学意义(P>005);达标组新生儿甲减发生率为423%,低于未达标组2083%(P<005)。结论 妊娠合并甲减会增加新生儿甲减的发生率,给予LT4治疗,可降低新生儿甲减发生率,尤其是TSH达标孕妇。

    Abstract:

    【Abstract】 Objective To investigate the relationship between maternal hypothyroidism and neonatal hypothyroidism and the effect of TSH goaldirected therapy on the incidence of neonatal hypothyroidism. Methods 58 pregnant women with hypothyroidism and 67 pregnant women with subclinical hypothyroidism treated in our hospital between January 2012 and January 2015 were included in the clinical hypothyroidism group and subclinical hypothyroidism group, respectively. Another 60 pregnant women with normal thyroid function underwent pregnancy test in the hospital during the same period were selected as control group. Among 125 pregnant women complicated with hypothyroidism, 95 cases were treated with levothyroxine (LT4) (LT4 treatment group), of whom 71 cases of serum thyroid stimulating hormone (TSH) reached the standard (standard group), while 24 cases of TSH (nonreaching standard group) did not and 3 cases missed LT4 treatment (non LT4 treatment group)On termination of pregnancy, the neonatal thyroid function parameters were compared between LT4 treatment group, non LT4 treatment group and control group. The incidence rates of neonatal hypothyroidism in all groups were recorded. Results The neonatal TSH in non LT4 treatment group was higher than that in LT4 treatment group and control group (P< 005). There was no significant difference between LT4 treatment group and control group (P > 005). There were no significant difference in serum free thyroxine (FT4) between pregnant women in the three groups (P > 005). The incidence of neonatal hypothyroidism in non LT4 treatment group (2333%) was higher than that in LT4 treatment group (842%) and control group (0).There was no significant difference between LT4 treatment group and the control group (P > 005). There was no significant difference in the incidence of neonatal hypothyroidism between clinical hypothyroidism group and subclinical hypothyroidism group (P > 005). The incidence of neonatal hypothyroidism in standard group (423%) was lower than that in nonreaching standard group (2083%) (P< 005). Conclusion Pregnancy complicated with hypothyroidism will increase the incidence of neonatal hypothyroidism. LT4 treatment can reduce the incidence of neonatal hypothyroidism, especially in pregnant women with standard TSH.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-06-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司